These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 9723313)

  • 1. Combined liver-kidney transplantation: long-term follow-up in 18 patients.
    Lang M; Kahl A; Bechstein WO; Neumann U; Settmacher U; Frei U; Neuhaus P
    Transplant Proc; 1998 Aug; 30(5):1865-7. PubMed ID: 9723313
    [No Abstract]   [Full Text] [Related]  

  • 2. Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study.
    Wong KM; Cheung CY; Chan YH; Chak WL; Choi KS; Chau KF; Li CS
    Transplant Proc; 2000 Nov; 32(7):1721-2. PubMed ID: 11119907
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563.
    Langrehr JM; Lohmann R; Raakow R; Jonas S; Klupp J; Bechstein WO; Neuhaus R; Neuhaus P
    Transplant Proc; 2001 May; 33(3):2290-1. PubMed ID: 11377531
    [No Abstract]   [Full Text] [Related]  

  • 4. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
    Reissi D; Bardideh A; Samadzadeh B; Razi A
    Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term comparison of tacrolimus and cyclosporine-based immunosuppression in kidney recipients with grafts from non-heart-beating cadaver donor.
    Kinukawa T; Ohshima S; Ono Y; Fujita T; Hattori R; Tanaka K
    Transplant Proc; 1998 Jun; 30(4):1227-9. PubMed ID: 9636498
    [No Abstract]   [Full Text] [Related]  

  • 6. FK506 for primary and rescue therapy following liver transplantation.
    Platz KP; Mueller AR; Zytowski M; Lobeck H; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1409-10. PubMed ID: 9636570
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term results of living kidney transplantation under tacrolimus immunosuppression: a single-center experience.
    Tanabe K; Ishikawa N; Tokumoto T; Takahashi K; Kanematsu A; Kitani R; Fuchinoue S; Oshima T; Yagisawa T; Toma H
    Transplant Proc; 1998 Jun; 30(4):1224-6. PubMed ID: 9636497
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression.
    Toda F; Tanabe K; Tokumoto T; Ishikawa N; Koga S; Ito S; Yagisawa T; Toma H
    Transplant Proc; 2000 Nov; 32(7):1726-9. PubMed ID: 11119909
    [No Abstract]   [Full Text] [Related]  

  • 9. Significance of a T-lymphocytotoxic crossmatch in liver and combined liver-kidney transplantation.
    Neumann UP; Lang M; Moldenhauer A; Langrehr JM; Glanemann M; Kahl A; Frei U; Bechstein WO; Neuhaus P
    Transplantation; 2001 Apr; 71(8):1163-8. PubMed ID: 11374419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantation.
    Klupp J; Glanemann M; Bechstein WO; Platz KP; Langrehr JM; Keck H; Settmacher U; Radtke C; Neuhaus R; Neuhaus P
    Transplant Proc; 1999; 31(1-2):1113-4. PubMed ID: 10083497
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk and benefit of antibody induction therapy in combination with tacrolimus immunosuppression after liver transplantation.
    Klupp J; Bechstein WO; Pratschke J; Tullius SG; Gebhard A; Lobeck H; Langrehr JM; Neuhaus R; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1443-4. PubMed ID: 9636585
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic rejection in pediatric liver transplantation.
    Cho JH; Bhatnagar V; Andreani P; Muiesan P; Portmann B; Baker A; Mieli-Vergani G; Gibbs P; Rela M; Heaton ND
    Transplant Proc; 1997; 29(1-2):452-3. PubMed ID: 9123078
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of tacrolimus in renal transplant recipients with immunoglobulin-A nephropathy.
    Suzuki K; Tanabe K; Tokumoto T; Shimizu T; Ishikawa N; Yagisawa T; Honda K; Nihei H; Toma H
    Transplant Proc; 2000 Nov; 32(7):1730-2. PubMed ID: 11119910
    [No Abstract]   [Full Text] [Related]  

  • 14. Tacrolimus/mycophenolate mofetil vs cyclosporine A/Azathioprine after simultaneous pancreas and kidney transplantation: five-year results of a randomized study.
    Woeste G; Wullstein C; Dette K; Pridöhl O; Lübke P; Bechstein WO
    Transplant Proc; 2002 Aug; 34(5):1920-1. PubMed ID: 12176629
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term results of kidney grafts surviving beyond the first year: comparison of cyclosporine-based regimens with the azathioprine and steroid regimen.
    Rizzolo M; Puggia R; Maresca MC; Calconi G; Vianello A
    Transplant Proc; 1998 Aug; 30(5):1751-2. PubMed ID: 9723266
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation.
    Bilbao I; Pou L; Allende E; Lázaro JL; Charco R; Hidalgo E; Margarit C
    Transplant Proc; 2001 May; 33(3):2124-6. PubMed ID: 11377472
    [No Abstract]   [Full Text] [Related]  

  • 17. A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation.
    Sperschneider H;
    Transplant Proc; 2001; 33(1-2):1279-81. PubMed ID: 11267291
    [No Abstract]   [Full Text] [Related]  

  • 18. Quadruple versus dual tacrolimus-based induction after liver transplantation: a prospective, randomized trial.
    Langrehr JM; Klupp J; Junge G; Jonas S; Neuhaus R; Bechstein WO; Neuhaus P
    Transplant Proc; 2001 May; 33(3):2330-1. PubMed ID: 11377549
    [No Abstract]   [Full Text] [Related]  

  • 19. Is the use of marginal liver grafts justified?
    Mueller AR; Platz KP; Krause P; Steinmüller T; Glanemann M; Neumann U; Lobeck H; Neuhaus P
    Transplant Proc; 1999; 31(1-2):401-2. PubMed ID: 10083160
    [No Abstract]   [Full Text] [Related]  

  • 20. Donor specific transfusion in kidney transplantation: effect of different immunosuppressive protocols on graft outcome.
    Barbari A; Stephan A; Masri MA; Joubran N; Dagher O; Kamel G
    Transplant Proc; 2001 Aug; 33(5):2787-8. PubMed ID: 11498161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.